Narcolepsy is a neurological disorder that affects the sleep-wake cycle, resulting in excessive daytime sleepiness, sleep paralysis, and cataplexy. It is often misdiagnosed or overlooked, leading to a delay in diagnosis and treatment. This article aims to provide an overview of the disorder, its symptoms, diagnosis, and management.
Narcolepsy is a sleep disorder characterized by excessive daytime sleepiness (EDS) and other symptoms including cataplexy, sleep paralysis, and hypnagogic hallucinations. It affects around 1 in 2,000 people, although the exact prevalence is unknown. Narcolepsy is caused by a disruption in the brain’s ability to regulate sleep and wakefulness. It is thought to be caused by a combination of genetic and environmental factors.
The most common symptom of narcolepsy is EDS, which is an overwhelming feeling of fatigue and sleepiness that cannot be alleviated by rest. Other symptoms include:
The diagnosis of narcolepsy is based on clinical history, physical examination, and laboratory tests. The most common laboratory tests used to diagnose narcolepsy include the multiple sleep latency test (MSLT) and the polysomnogram (PSG). The MSLT is a daytime test that measures how quickly a person falls asleep and how long they stay asleep. The PSG is an overnight test that records brain activity, breathing, and other body functions during sleep.
The goal of treatment is to improve the symptoms of narcolepsy and improve the quality of life. Treatment may include medications, lifestyle changes, and psychotherapy. Medications used to treat narcolepsy include stimulants, antidepressants, and sodium oxybate. Stimulants help to reduce daytime sleepiness and improve alertness. Antidepressants can help reduce cataplexy and hypnagogic hallucinations. Sodium oxybate is used to treat cataplexy and can improve nighttime sleep. Lifestyle changes such as regular exercise, a healthy diet, and avoiding caffeine and alcohol can also help to improve symptoms. Psychotherapy can help with stress management and coping with the emotional impact of the disorder.
Narcolepsy is a neurological disorder that affects the sleep-wake cycle, resulting in excessive daytime sleepiness, sleep paralysis, and cataplexy. It is often misdiagnosed or overlooked, leading to a delay in diagnosis and treatment. Treatment of narcolepsy includes medications, lifestyle changes, and psychotherapy. It is important to seek medical advice if you think you may have narcolepsy, as early diagnosis and treatment can help to reduce the impact of the disorder.
1.
Certain surgical gestures during prostate removal linked to better sexual function recovery
2.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
3.
In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.
4.
An "exploding" field of antibody-drug conjugates is making progress against ovarian cancer.
5.
Black women have a higher risk of dying from all types of breast cancer, meta-analysis reveals
1.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
2.
Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After
3.
What Is A Normal Fibrinogen Level, And How Can It Affect Your Health
4.
Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments
5.
ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
2.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
4.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation